Clonazepam and Alimta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clonazepam (clonazepam) and Alimta (pemetrexed disodium). Common drug interactions include pneumonia among females and thrombocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Clonazepam and Alimta. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Clonazepam?

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. eHealthMe is studying from 146,270 Clonazepam users. Check the latest studies of Clonazepam.

What is Alimta?

Alimta has active ingredients of pemetrexed disodium. eHealthMe is studying from 7,702 Alimta users. Check the latest studies of Alimta.

On Jul, 19, 2026

23 people who take Clonazepam and Alimta together, and have interactions are studied.

Clonazepam and Alimta drug interactions.

What are the common drug interactions of Clonazepam and Alimta, by gender? *:

female:

Pneumonia
Pyrexia (fever)
Neutropenia (an abnormally low number of neutrophils)
Chest pain
Dyspnoea (difficult or laboured respiration)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)

male:

Thrombocytopenia (decrease of platelets in blood)
Segmented hyalinising vasculitis (a chronic relapsing inflammatory condition of the blood vessels of the lower legs associated with nodular or purpuric skin lesions)
Pleural effusion (water on the lungs)
Pyrexia (fever)
Somnolence (a state of near-sleep, a strong desire for sleep)
Septic shock (shock due to blood infection)
Coagulation time prolonged
Cytolytic hepatitis (dissolution or destruction of a liver cell)
Disease progression
Fall

What are the common drug interactions of Clonazepam and Alimta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cardiotoxicity (damage to the heart muscle)
Congestive cardiomyopathy (weakening of heart muscle)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Ejection fraction decreased (systolic heart failure)
Fatigue (feeling of tiredness)
Pleural effusion (water on the lungs)
Pneumonia
Somnolence (a state of near-sleep, a strong desire for sleep)
Neutropenia (an abnormally low number of neutrophils)
Angioedema (rapid swelling of the dermis)

60+:

Thrombocytopenia (decrease of platelets in blood)
Segmented hyalinising vasculitis (a chronic relapsing inflammatory condition of the blood vessels of the lower legs associated with nodular or purpuric skin lesions)
Transaminases increased
Septic shock (shock due to blood infection)
Cytolytic hepatitis (dissolution or destruction of a liver cell)
Neutropenia (an abnormally low number of neutrophils)
Leukocytoclastic vasculitis (inflammation of small blood vessels (usually post-capillary venules in the dermis), characterized by palpable purpura)

What are the existing conditions these people have? *

Lung Cancer Metastatic (lung cancer spreads to other parts): 8 people, 34.78%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 13.04%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 8.70%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.70%
Cancer Pain: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Clonazepam and Alimta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously